HK1078463A1 - Novel combination of glucocorticoids and pde-4 inhibitors for treating respiratory deiseases, allergic diseases, asthma and corp - Google Patents

Novel combination of glucocorticoids and pde-4 inhibitors for treating respiratory deiseases, allergic diseases, asthma and corp

Info

Publication number
HK1078463A1
HK1078463A1 HK05110373A HK05110373A HK1078463A1 HK 1078463 A1 HK1078463 A1 HK 1078463A1 HK 05110373 A HK05110373 A HK 05110373A HK 05110373 A HK05110373 A HK 05110373A HK 1078463 A1 HK1078463 A1 HK 1078463A1
Authority
HK
Hong Kong
Prior art keywords
pde
asthma
novel combination
deiseases
glucocorticoids
Prior art date
Application number
HK05110373A
Other languages
English (en)
Inventor
Mathias Locher
Robert Hermann
Original Assignee
Meda Pharma Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meda Pharma Gmbh & Co Kg filed Critical Meda Pharma Gmbh & Co Kg
Publication of HK1078463A1 publication Critical patent/HK1078463A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK05110373A 2002-08-09 2005-11-18 Novel combination of glucocorticoids and pde-4 inhibitors for treating respiratory deiseases, allergic diseases, asthma and corp HK1078463A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10236688 2002-08-09
PCT/EP2003/008607 WO2004019984A1 (de) 2002-08-09 2003-08-04 Neue kombination von glucocorticoiden und pde-4-inhibitoren zur behandlung von atemwegserkrankungen, allergischen erkrankungen, asthma und copd

Publications (1)

Publication Number Publication Date
HK1078463A1 true HK1078463A1 (en) 2006-03-17

Family

ID=31968961

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05110373A HK1078463A1 (en) 2002-08-09 2005-11-18 Novel combination of glucocorticoids and pde-4 inhibitors for treating respiratory deiseases, allergic diseases, asthma and corp

Country Status (19)

Country Link
US (1) US20050288265A1 (da)
EP (1) EP1526870B1 (da)
JP (1) JP2005539042A (da)
CN (1) CN1308038C (da)
AT (1) ATE361076T1 (da)
AU (1) AU2003255365B2 (da)
CA (1) CA2492645A1 (da)
CY (1) CY1107696T1 (da)
DE (1) DE50307184D1 (da)
DK (1) DK1526870T3 (da)
EA (1) EA008981B1 (da)
ES (1) ES2285238T3 (da)
HK (1) HK1078463A1 (da)
HR (1) HRP20050224B1 (da)
MX (1) MXPA05001573A (da)
NO (1) NO20051212D0 (da)
PT (1) PT1526870E (da)
UA (1) UA82323C2 (da)
WO (1) WO2004019984A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10241407A1 (de) * 2002-09-06 2004-03-18 Elbion Ag Behandlung nicht allergischer Rhinitis durch selektive Phosphodiesterase 4-Hemmstoffe
ATE541570T1 (de) 2004-02-06 2012-02-15 Meda Pharma Gmbh & Co Kg Kombination von anticholinergika und hemmern von phosphodiesterase typ 4 zur behandlung von atemwegserkrankungen
CA2551780C (en) 2004-02-06 2013-02-26 Meda Pharma Gmbh & Co. Kg The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd
HUE027076T2 (en) 2005-03-16 2016-08-29 Meda Pharma Gmbh & Co Kg Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
CA2824075C (en) 2005-12-21 2015-04-28 Joachim Maus Combination of r, r-glycopyrrolate, formoterol, and a glucocorticoid for the treatment of inflammatory diseases
CA2644889A1 (en) * 2006-03-07 2007-09-13 Combinatorx, Incorporated Compositions and methods for the treatment of immunoinflammatory disorders
US8293489B2 (en) 2007-01-31 2012-10-23 Henkin Robert I Methods for detection of biological substances
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
CN102309756A (zh) * 2010-07-02 2012-01-11 天津金耀集团有限公司 含有磷酸二酯酶4抑制剂和糖皮质激素的治疗皮肤病的复方药物
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US10864219B2 (en) 2012-05-03 2020-12-15 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
KR102310775B1 (ko) 2012-05-03 2021-10-07 칼라 파마슈티컬스, 인크. 개선된 점막 수송을 나타내는 제약 나노입자
AU2013256064B2 (en) * 2012-05-03 2018-01-04 Alcon Inc. Pharmaceutical nanoparticles showing improved mucosal transport
US20160030435A1 (en) * 2013-03-15 2016-02-04 Robert I HENKIN Phosphodiesterase inhibitor treatment
EP3108245B1 (en) 2014-02-18 2020-07-22 Robert I. Henkin Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE449106B (sv) * 1980-07-10 1987-04-06 Otsuka Pharma Co Ltd Steroid med anti-inflammatorisk verkan samt komposition innehallande denna
US4996335A (en) * 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
PT1014943E (pt) * 1997-02-05 2002-11-29 Jago Res Ag Formulacoes medicinais de aerossois
DE19917504A1 (de) * 1999-04-17 2000-10-19 Dresden Arzneimittel Verwendung von Hydroxyindolen, die Inhibitoren der Phosphodiesterase 4 sind, zur Therapie chronisch obstruktiver Lungenerkrankungen
EP1076657B1 (de) * 1998-04-28 2004-08-04 elbion AG Neue hydroxyindole, deren verwendung als inhibitoren der phosphodiesterase 4 und verfahren zu deren herstellung
DE19947234A1 (de) * 1999-09-30 2001-04-05 Asta Medica Ag Neue Kombination von Loteprednol und Antihistaminika
AR029189A1 (es) * 1999-11-02 2003-06-18 Smithkline Beecham Corp Uso de un inhibidor de fosfodiesterasa 4 y un corticoesteroide antiinflamatorio en forma combinada, separadamente o separadamente secuencial para la preparacion de un medicamento
US20040214805A1 (en) * 1999-11-02 2004-10-28 Smithkline Beecham Corporation Method and compositions for treating pulmonary diseases
PT1289945E (pt) * 2000-05-19 2004-10-29 Alcon Inc Derivados dissulfureto de anilina para o tratamento de doencas alergicas
GB0123951D0 (en) * 2001-10-05 2001-11-28 Glaxo Group Ltd Therapies for treating respiratory diseases
BR0213683A (pt) * 2001-11-05 2004-10-26 Merck Patent Gmbh Hidrazono-malonitrilas
US20030092706A1 (en) * 2001-11-09 2003-05-15 Johannes Barsig Combination

Also Published As

Publication number Publication date
EP1526870A1 (de) 2005-05-04
HRP20050224A2 (en) 2005-04-30
ES2285238T3 (es) 2007-11-16
EA008981B1 (ru) 2007-10-26
ATE361076T1 (de) 2007-05-15
CA2492645A1 (en) 2004-03-11
DK1526870T3 (da) 2007-09-10
DE50307184D1 (de) 2007-06-14
UA82323C2 (uk) 2008-04-10
CY1107696T1 (el) 2013-04-18
NO20051212L (no) 2005-03-08
AU2003255365B2 (en) 2009-02-19
PT1526870E (pt) 2007-07-09
CN1674939A (zh) 2005-09-28
MXPA05001573A (es) 2005-04-25
US20050288265A1 (en) 2005-12-29
HRP20050224B1 (en) 2007-12-31
WO2004019984A1 (de) 2004-03-11
JP2005539042A (ja) 2005-12-22
EP1526870B1 (de) 2007-05-02
AU2003255365A1 (en) 2004-03-19
CN1308038C (zh) 2007-04-04
EA200500328A1 (ru) 2005-06-30
NO20051212D0 (no) 2005-03-08

Similar Documents

Publication Publication Date Title
HK1078463A1 (en) Novel combination of glucocorticoids and pde-4 inhibitors for treating respiratory deiseases, allergic diseases, asthma and corp
MXPA02011311A (es) Composicion novedosa.
WO2003000241A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika; corticosteroiden und betamimetika zur behandlung von entzündlichen und/oder obstruktiven atemwegserkrankungen
CA2474479A1 (en) Composition for inhalation
WO2005041864A3 (en) Combination of cyclooxygenase-2 inhibitor and phosphodiesterase 4 inhibitor and method
IS2575B (is) Ný samverkandi samsetning sem felur í sér róflúmílast og formóteról
MXPA05009986A (es) Tratamiento de la enfermedad de alzheimer.
WO2007044325A3 (en) Apoe4 domain interaction inhibitors and methods of use thereof
UA42719C2 (uk) Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб
DE602007014067D1 (de) Zusammensetzungen und verfahren zur behandlung, kontrolle, verminderung, verbesserung bzw. prävention von allergien
TW200700075A (en) Roflumilast and integrin inhibitor combination and method of treatment
IS7899A (is) Samverkandi samsetning sem felur í sér róflúmílast og (R.R)-formóteról
MY130725A (en) Composition and method for treating allergic diseases
SE9900834D0 (sv) Novel combination
MXPA04007294A (es) Composicion para inhalacion.
WO2003094968A3 (en) Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases
MX2007007051A (es) Nuevos derivados de tiofenpirimidiona sustituida como inhibidores de la 17??-hidroxiesteroide deshidrogenasa.
MY133181A (en) Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
ATE526954T1 (de) Atomoxetin zur behandlung von allergischer rhinitis und asthma
ECSP993168A (es) Composicion y metodo para tratar enfermedades alergicas

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110804